Financhill
Back

Viking Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.

Viking Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 51.82 Buy
20-day SMA: 61.71 Sell
50-day SMA: 63.78 Sell
200-day SMA: 62.22 Sell
8-day EMA: 53.58 Sell
20-day EMA: 58.46 Sell
50-day EMA: 61.44 Sell
200-day EMA: 55.59 Sell

Viking Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.14 Sell
Relative Strength Index (14 RSI): 37.36 Sell
Chaikin Money Flow: -474198 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.05 - 71.73) Sell
Bollinger Bands (100): (54.01 - 67.19) Sell

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Viking Therapeutics Stock

Is Viking Therapeutics Stock a Buy?

VKTX Technical Analysis vs Fundamental Analysis

Sell
38
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy or a Sell?

Viking Therapeutics Stock Info

Market Cap:
5.86B
Price in USD:
52.59
Share Volume:
2.57M

Viking Therapeutics 52-Week Range

52-Week High:
99.41
52-Week Low:
11.55
Sell
38
Viking Therapeutics (VKTX) is a Sell

Viking Therapeutics Share Price Forecast

Is Viking Therapeutics Stock a Buy?

  • Viking Therapeutics share price is 52.59 while VKTX 8-day exponential moving average is 53.58, which is a Sell signal.
  • The stock price of VKTX is 52.59 while Viking Therapeutics 20-day EMA is 58.46, which makes it a Sell.
  • Viking Therapeutics 50-day exponential moving average is 61.44 while VKTX share price is 52.59, making it a Sell technically.
  • VKTX stock price is 52.59 and Viking Therapeutics 200-day simple moving average is 55.59, creating a Sell signal.

Fundamental Analysis of Viking Therapeutics

Is Viking Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.48 per share.

Technical Analysis of Viking Therapeutics

Should I short Viking Therapeutics stock?

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.